CBA. Center of Excellence. Integration of Biomedical and Behavioral Interventions for HIV Prevention

Similar documents
High Impact HIV Prevention Services and Best Practices

Implementation of testing (and other interventions along the Continuum of Care)

The Syndemics of HIV, Hepatitis, and Overdose

High Impact Prevention: Science, Practice, and the Future of HIV

ViiV Healthcare s Position on Prevention in HIV

HIV PREVENTION: NHAS TO HIP

Looking to the Future in HIV Prevention:

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

As a result of this training, participants will be able to:

2010 HIV Prevention Plan and HIV Prevention Section Update

Stigma and HIV. Maria E. Alvarez, MPA. LEAD PUBLIC HEALTH ADVISOR Team Lead, Capacity Building Branch Partnerships Team

Moving Integrated HIV Prevention and Care Planning into Action: Integrated Funding for HIV Services. Wednesday, June 13, :00 p.m. 4:00 p.m.

The HIV Prevention England programme: what s next? Cary James May 2016

Program Collaboration and Service Integration

PS : Comprehensive HIV Prevention Programs for Health Departments

Providing Good Care to People Living with HIV

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections

Behavioral Interventions For Prevention And Control Of Sexually Transmitted Diseases READ ONLINE

Connecting the Community. Advancing the HIV Response in Baltimore and Jackson.

As a result of this training, participants will be able to:

Florida s HIV Testing Efforts

Syringe Exchange Programs December 2005

HIV Treatment as Prevention (TasP)

2020 Vision: making England s HIV prevention response the best in the world

Culturally Relevant Linkages to Care

>Hepatitis NSW will continue to

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

The Past as Prologue: Emerging needs and future directions in research on HIV prevention and treatment among MSM

World Health Organization. A Sustainable Health Sector

The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA)

KENYA AIDS STRATEGIC FRAMEWORK 2014/ /2019

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016

ENDING THE EPIDEMICS: A NATIONAL, STATE, AND CITY APPROACH

Emma Zurowski PaSH Programme Lead BHA for Equality. Peter Bampton Sexual Health Lead LGBT Foundation. gmpash.org.uk.

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

Implementation of the National HIV/AIDS Strategy in San Francisco. San Francisco Department of Public Health Health Commission November 16, 2010

Social Marketing Campaign for STD/HIV Prevention. Hilda Sandoval, PhD, LMFT AltaMed Health Services

TB/HIV Care s Experience Setting up PrEP Sites and Engaging Potential Service Users. John Mutsambi and Peggy Modikoe TB/HIV Care

Be The Change II Presents. KNOW YOUR LANE: High-Impact Prevention Made Easy

Getting To Zero A Framework to Eliminate HIV in Illinois

Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

Mother-to-Child transmission of hiv and neonatal hiv ManageMent

PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES

HIV Prevention Prioritization & Implementation Brief: Kaduna State

City of Chicago Department of Public Health Pre-Announcement of the HIV Prevention Request for Proposals (RFP)

GEORGIA STATEWIDE MSM STRATEGIC PLAN

YOU ARE NOT ALONE Health and Treatment for HIV Positive Young Men of Color

Government of Canada Federal AIDS Initiative Milestones

Surveillance of Recent HIV Infections: Using a Pointof-Care Recency Test to Rapidly Detect and Respond to Recent Infections

Advancing the National HIV/AIDS Strategy: Housing and the HCCI. Housing Summit Los Angeles, CA

Miami-Dade County Getting to Zero HIV/AIDS Task Force Implementation Report

BHIVA Satellite Symposium. Tougher Times: Adapting to Increasing Demand with Declining Resources

Participant Autonomy and HCV Elimination:

HIV Prevention Prioritization & Implementation Brief: Gombe State

Evidence-based Strategies to Address Retention in HIV Care

GETTING TO ZERO AND ENDING THE EPIDEMIC

FY 17 EIIHA PLAN Early Identification of Individuals with HIV/AIDS

Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically -

Harm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner

Version for the Silent Procedure 29 April Agenda item January Hepatitis

UK Department for International Development: Joining forces in the development of new prevention technologies

Partners in Prevention: An Introduction to Biomedical Counseling for PrEP. Robert Maher TOUCH Penelope Demas Jacobi Medical Center Lynnette Ford GMHC

Background. Background Epidemiology. Stop TB in the African-American Community. Stop TB in the African-American Community

TRANS-NIH PLAN FOR HIV RELATED RESEARCH

HIV Prevention Service Provider Survey 2014

Viral Load Suppression/Any HIV Care 84%

Day Seven: Helping HIV Affected Children and Orphans

Getting To Zero. A Framework to Eliminate HIV in Illinois. Getting to Zero Exploratory Workgroup. June 6, 2017

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Digital Adherence Interventions: A Review of CDC Investments in IT-Based Technologies

HIV PREP THE NEWEST TOOL IN THE BOX

Hepatitis C in Massachusetts Epidemiology and Public Health Response

Available In person Courses

Program to control HIV/AIDS

A guide for hospitals & healthcare facilities in rural areas

CHANGING THE HIV/AIDS PARADIGM Strategic Plan FY 2014/15 FY 2019/20

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

Outline. Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs

FIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH

Health Department Role: Eliminating HBV and HCV

HIV WHAT WORKERS NEED TO KNOW

Community Client Tracing Through Mentor Mothers in the Democratic Republic of the Congo

Needle and Syringe Programs - 17 October 2013

HIV Prevention Prioritization & Implementation Brief: Anambra State

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

Post-exposure prophylaxis (PEP)

Integrating Hepatitis Services into HIV Programs: The Local Health Department Perspective

The Latest on HIV Testing. Dominika Seidman, MD MAS

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs

IFMSA Policy Statement Ending AIDS by 2030

Ending HIV and Australia s success story in PrEP implementation Dr Heather-Marie Schmidt

Infectious Diseases Florida Department of Health, HIV/AIDS Section/ Division of Disease Control and Health Protection Tallahassee, Florida

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

New Mexico HCV Elimination

April 20, 2016 TESTIMONY OF PATRICK BEATTY, ESQ.

HIV Prevention Prioritization & Implementation Brief: Benue State

Transcription:

CB Capacity Building ssistance Integration of Biomedical and Behavioral Interventions for HIV Prevention The integration of biomedical and behavioral interventions in HIV prevention can be defined as addressing the medical component of treatment in addition to addressing knowledge, attitudes and behavior regarding the virus. Some sources of innovation for the next generation of HIV prevention may include: Effective HIV prevention requires a combination of behavioral, biomedical, and structural intervention strategies. 2 Evidence-Based Interventions (EBIs) and Diffusion of Evidence-Based Interventions (DEBIs) play an important role in reducing the incidence of the acquisition and transmission of HIV. Biomedical strategies represent the cornerstone for the CDC s High-Impact Prevention approach, which aims to minimize the number of new HIV infections. However, the availability of biomedical prevention tools is only one part of the equation toward ending the epidemic. These tools need to be understood, effectively used, and sustained by those who utilize them. With new bio-medical prevention tools we can even interrupt acquisition of the virus as well. Surveillance tools have improved as well with geo-mapping increasingly used to identify areas with high HIV/IDS infection rates. lthough there have been many biomedical breakthroughs, health literacy among providers and consumers is lacking. In order for the plethora of advances in the prevention and treatment of HIV to be effective, providers and patients must understand and acknowledge their own personal and organizational deficiencies. Next they must move forward with strong efforts to increase their capacity to effectively serve their communities. In order for the biomedical prevention tools to be implemented successfully, providers and patients must understand them, believe in them, and know how to use them. 3 Evidence-based intervention (EBI) development and adaptation Use of a continuous quality improvement paradigm in the creation, design, and dissemination of EBIs Utilization of business principles from marketers and entrepreneurs to facilitate design and diffusion of EBIs Reframing prevention from a diseasemanagement to a wellness perspective framework that reinforces HIV as a chronic disease Moving prevention from healthcare settings to community sites 1 In collaboration with Evidence-Based Interventions and Diffusion of Evidence-Based Interventions One way of reducing the number of new HIV infections is through the use of Evidence-Based Interventions (EBIs) and Diffusion of Evidence-Based Interventions (DEBIs). Rotheram-Borus et al. (2009) writes the strategies supporting the efficacy of EBIs are remarkably common across theories and include provision of information; shaping of attitudes, norms, self-efficacy, and motivation; and building behavioral skills 4. n increased focus on evidence-based public health strategies has numerous direct and indirect benefits, including access to more and higher-quality public health information, a higher likelihood of successful programs and better implementation of policies. Often EBIs are more effective when implementers and clients are similar in terms of ethnicity, gender, age, and behavioral and background characteristics 5. EBIs promote treatments meant to change a health behavior. Cicatelli ssociates Inc. www.hivcbacenter Funded by the CDC Grant #8754

CB Capacity Building ssistance The validation process for EBIs involves multiple trials with groups or individuals. To achieve state and national objectives for population health, more widespread adaptation of evidencebased strategies is implemented. There are a number of confounders that can make an EBI unsuccessful in certain environments. For example, confounders such as transportation, attendance, incentives for participants, interest, subject matter, even the day of the week can all sway a very effective EBI into an unsuccessful venture and cause the intervention to lose integrity. Discussing the participants preferences and needs can help to make the intervention more effective for both the facilitator and the attendees. EBIs and DEBIs allow for a multifarious way of communicating and training lay individuals or groups to reduce risk behaviors. One goal of an EBI or DEBI is to acknowledge an individual or group s current behaviors and equip them to move forward with healthier life practices. Each intervention is tailored towards specific groups varying from high-risk negatives to those who are newly diagnosed with HIV. Individual, small-group, and community interventions for people at high risk of HIV infection can reduce risk behavior and can play an important part in comprehensive HIV prevention strategies 7. nother goal of EBIs and DEBIs is to ensure that they are realistic and sustainable for your population of interest. DEBIs began in 1999 when the Centers for Disease Control and Prevention (CDC) published a Compendium of HIV Prevention Interventions with Evidence of Effectiveness in response to prevention service providers who requested effective evidence-based interventions 6. Disseminating EBIs is essential in order to build capacity of HIV prevention programs. For example, if your goal is to increase physical activity by forming neighborhood walking groups in an area that doesn t have street lights, sidewalks, and has a high crime rate, the intervention will not be successful or sustainable. Equipping your population of interest with the necessary tools will make the interventions both successful and sustainable. nother way to look at sustainability is to build in a check-in or follow-up component of the project after the intervention is complete. For example, one might host an event for those who have completed an intervention to meet three months after the intervention to follow-up on their current behavior. This would allow for feedback and also opportunities to collect data to inform improvements of the interventions. Behavior change is the crux of an intervention. Increasing knowledge and attempting to identify and become more aware of one s personal attitudes towards a behavior can indeed lead a participant closer to change. High-Impact Prevention High-Impact Prevention (HIP), as described by the CDC, is an approach that uses combinations of scientifically proven, cost-effective, and scalable interventions targeted to the right populations in the right geographic areas in order to increase the impact of HIV prevention efforts 8. To advance the prevention of goals of National HIV/IDS Strategy (NHS) and maximize the effectiveness of current HIV prevention methods, the CDC pursues a High-Impact Prevention approach. By using combinations of scientifically proven, cost-effective, and scalable interventions targeted to the right populations in the right geographic areas, this approach promises to greatly increase the impact of HIV prevention efforts Cicatelli ssociates Inc. www.hivcbacenter Funded by the CDC Grant #8754

CB Capacity Building ssistance - an essential step in achieving the goals of NHS9. When using the High-Impact Prevention approach, there are five major components to consider: 1 2 3 4 5 Effectiveness and cost Feasibility of full-scale implementation Coverage in the target populations Interaction and targeting Prioritization Infusing these components into the EBIs provide for effective dissemination of information that combats stigma, myths, and fears while raising awareness that can provide for a great platform to reach the goals of NHS. Some proven HIP Interventions include: HIV and linkage to care, antiretroviral therapy, access to condoms and sterile syringes, prevention programs for people living with HIV and their partners, preventions programs for people at high risk of infection, substance abuse treatment, and screening and treatment for other sexually transmitted diseases. Train-the-Trainer Below you will learn about the benefits and lessons of using the train-the-trainer method when implementing an EBI. The advantage of local trainers who are more familiar with contextual issues to allow for tailoring of the training Enhanced collaboration among practice and academic partners to create a forum for networking and new partnership opportunities Benefits and lessons of the train-the-trainer model Specific examples of how to improve the course in the future more convenient and less costly method of training that eliminates the need to bring in external trainers or for participants to travel out of state to attend trainings Cicatelli ssociates Inc. www.hivcbacenter Funded by the CDC Grant #8754

CB Capacity Building ssistance This evaluation suggests that the train-the-trainer method has increased the capacity of practitioners trained in evidence-based public health while maintaining the original objectives and framework of the course. The train-the-trainer method also addresses medical mistrust among communities. Training members of a community to share medical knowledge with other members of the same community may assist in breaking down the barrier of mistrust. Cost Effectiveness of EBIs and DEBIs Cost-effectiveness analysis is a type of economic analysis where both the cost and the outcome (e.g. impact, result, effect, benefit, health gain) of an intervention are evaluated and then expressed in the form of a cost-effectiveness ratio. The cost effectiveness of interventions can vary based on your population of interest, resources available, and other confounders. Farnham et al. (2010) measured the value of HIV prevention efforts in the United States by comparing the difference between the number of infections that occurred with the number that might have occurred in the absence of prevention programs. Combined with estimates of lifetime treatment costs 10, the study estimated the medical savings from infections averted by US prevention programs from 1991-2006 to be $129.9 billion with 361,878 HIV infections averted 11. From both a financial and health standpoint, the prevention efforts are well worth the cost. 1 Mary Jane Rotheram-Borus et al; (2009) The Past, Present, and Future of HIV Prevention: Integrating Behavioral, Biomedical, and Structural Intervention Strategies for the Next Generation of HIV Prevention, nnual Review Clinical 2 Mary Jane Rotheram-Borus et al; (2009) The Past, Present, and Future of HIV Prevention: Integrating Behavioral, Biomedical, and Structural Intervention Strategies for the Next Generation of HIV Prevention, nnual Review Clinical 3 The Black IDS Institute. When We Know Better, We Do Better :The State of HIV/IDS Science and Treatment Literacy.in the HIV/IDS Workforce. https://www.blackaids.org/reports 4 Mary Jane Rotheram-Borus et al; (2009) The Past, Present, and Future of HIV Prevention: Integrating Behavioral, Biomedical, and Structural Intervention Strategies for the Next Generation of HIV Prevention, nnual Review Clinical 5 Mary Jane Rotheram-Borus et al; (2009) The Past, Present, and Future of HIV Prevention: Integrating Behavioral, Biomedical, and Structural Intervention Strategies for the Next Generation of HIV Prevention, nnual Review Clinical 6 CDC. Effective Interventions: HIV Prevention That Works. https://www.effectiveinterventions.org 7 CDC. Evolution of HIV/IDS prevention programs United States, 1981-2006. MMWR 2006; 55:597-603. 8 Levine S, Brett B, Robinson BE, Stratos G, Lascher SM, Granville L, et al. Practicing physician education in geriatrics: lessons learned from a train-the-trainer model. J m Geriatr Soc. 2007;55(8):1281 6. doi: 10.1111/j.1532-5415.2007.01205.x. [PubMed] [Cross Ref] 9 CDC. http://www.cdc.gov/hiv/policies/hip/hip.html 10 Levine S, Brett B, Robinson BE, Stratos G, Lascher SM, Granville L, et al. Practicing physician education in geriatrics: lessons learned from a train-the-trainer model. J m Geriatr Soc. 2007;55(8):1281 6. doi: 10.1111/j.1532-5415.2007.01205.x. [PubMed] [Cross Ref] 11 Farnham PG, Holtgrave DR, Sansom SL, Hall HI. Medical costs averted by HIV prevention efforts in the United States, 1991-2006. JIDS 2010; 54(5): 565-567. Cicatelli ssociates Inc. www.hivcbacenter Funded by the CDC Grant #8754

CB Capacity Building ssistance Resources for Health Care Providers IDS.gov. Pre-Exposure Prophylaxis (PrEP). May 2014. http://www.aids.gov/hiv-aids-basics/prevention/reduce-your-risk/pre-exposureprophylaxis/ Centers for Disease Control and Prevention, US Public Health Service. Pre-exposure Prophylaxis for the Prevention of HIV Infection in the United States-2014 Clinical Practice Guideline. http://www.cdc.gov/hiv/pdf/guidelines/prepguidelines2014.pdf Centers for Disease Control and Prevention, US Public Health Service. Pre-exposure Prophylaxis for the Prevention of HIV Infection in the United States-2014 Clinical Providers; Supplement. http://www.cdc.gov/hiv/pdf/prepprovidersupplement2014.pdf Centers for Disease Control and Prevention, Division of HIV/IDS Prevention, National Center for HIV/IDS, Viral Hepatitis, STD, and TB Prevention. Pre-Exposure Prophylaxis (PrEP) for HIV Prevention. May 2014 http://www.cdc.gov/hiv/pdf/prep_fact_sheet_final.pdf Centers for Disease Control and Prevention, Division of HIV/IDS Prevention, National Center for HIV/IDS, Viral Hepatitis, STD, and TB Prevention. PrEP Infographic: Talk to your Doctor about PrEP. http://www.cdc.gov/hiv/basics/prep.html Gilead Sciences, Educational Materials for Providers and Patients http://www.truvadapreprems.com/ National lliance of State & Territorial IDS Directors. Fact sheet: Pharmaceutical Company Patient ssistance Programs and Co- Payment ssistance Programs for Pre-exposure Prophylaxis (PrEP) and Post-exposure Prophylaxis (PEP). http://www.nastad.org/docs/ PrEP%20and%20PEP%20PP%20fact%20sheet.pdf New York State Department of Health, IDS Institute, HIV, HCV & STD Clinical Education Initiative. Learning Modules: HIV Prevention with Pre-Exposure Prophylaxis Video Presentation. ugust 2014 http://www.ceitraining.org/resources/audio-video-detail. cfm?mediaid=320#.vic9lsgaig PrEP Support Hotline for Clinicians. PrEPline, 1-855-448-7737 (1-855 HIV-PREP). The CCC Pre-Exposure Prophylaxis Service Project Inform. PrEP (Pre-Exposure Prophylaxis) http://www.projectinform.org/prep Project Inform. Talking to patients about Pre-Exposure Prophylaxis. http://www.projectinform.org/pdf/prep_providers.pdf San Francisco IDS Foundation (February 2014). PrEP Facts Brochure. http://prepfacts.org/assets/prep_facts_16-pager_brochure_ mech_finl.pdf Cicatelli ssociates Inc. www.hivcbacenter Funded by the CDC Grant #8754